OAM
REGN icon

OP Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

OP Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Buy
14,139
+2,424
+21% +$1.86M 0.11% 124
2025
Q4 		$9.04M Buy
11,715
+59
+0.5% +$40.1K 0.11% 146
2025
Q3 		$6.55M Buy
11,656
+311
+3% +$176K 0.08% 186
2025
Q2 		$5.96M Sell
11,345
-354
-3% -$198K 0.09% 191
2025
Q1 		$7.42M Buy
+11,699
New +$8.05M 0.12% 143

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OP Asset Management's REGN Position: Q1 2026 in Review

OP Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q1 2026, buying an estimated $1.86M and bringing the position to 14,139 shares worth $10.9M. The position accounts for 0.11% of the portfolio, ranked #124.

OP Asset Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • OP Asset Management held 14,139 shares of Regeneron Pharmaceuticals worth $10.9M as of Q1 2026.
  • OP Asset Management bought 2,424 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.86M.
  • Regeneron Pharmaceuticals made up 0.11% of OP Asset Management's portfolio in Q1 2026, its #124 holding.
  • OP Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.